Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 2,148.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 0
  • Market Cap: £5,042m
  • RiskGrade: 125

Company Description

Drugs group Hikma, the first Jordanian company to list in London, makes branded prescription medicines and generic drugs.

IPO Details

Issue Date 01-Nov-2005 Prospectus n/a
Issue Price 290.00p Lead Broker Merrill Lynch
Market Cap £483.00m Contact Tel 020 7628 1000
Method Placing    
Sector Pharmaceuticals & Biotechnology    
Market Main    
Amount Raised £69.89m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 2,148.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 0
Shares Issued 234.72m
Market Cap £5,042m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.78% below the market average91.78% below the market average91.78% below the market average91.78% below the market average91.78% below the market average
48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average
Price Trend
66.00% above the market average66.00% above the market average66.00% above the market average66.00% above the market average66.00% above the market average
74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average
Income
6.43% below the market average6.43% below the market average6.43% below the market average6.43% below the market average6.43% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
30.47% above the market average30.47% above the market average30.47% above the market average30.47% above the market average30.47% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page